Dr David Grimes

MBBS (Qld), FRACP
Medical Oncologist
Become a Patient

Biography

Dr David Grimes is a medical oncologist at Icon Cancer Centre Wesley and Icon Cancer Centre North Lakes. He also regularly visits North West Private Hospital and Greenslopes Private Hospital. Dr Grimes graduated from the University of Queensland in 1984 and became a fellow of the Royal Australasian College of Physicians in 1992.

Following successful residencies at The Princess Alexandra Hospital and registrar and senior registrar positions at The South Brisbane Haematology/Oncology Unit and The Queensland Radium Institute at Royal Brisbane Hospital, Dr Grimes completed a clinical fellowship at the Roswell Park Cancer Institute New York in 1993 and 1994 specialising in bone marrow transplantation and medical oncology.

Dr Grimes continues to participate in clinical research and serves on several national advisory boards, he has, since its inception been convener for The South East Queensland Oncology group. His clinical experience covers a broad range of solid tumour malignancies, with special clinical interest in breast cancer, gastrointestinal cancer, genitourinary cancer, colorectal cancer, prostate cancer, pancreatic cancer, gynaecological cancer and thoracic cancers.

Affiliations & Memberships

  • Australian and New Zealand Germ Cell Trial Group
  • American Society of Clinical Oncology (ASCO)
  • Clinical Oncological Society of Australia (COSA)
  • Medical Oncology Group of Australia (MOGA)
  • Royal Australasian College of Physicians (RACP)

Special Interests

Dr David Grimes accepts referrals for all cancer types, with a special clinical interest in:
  • Breast cancer
  • Gastrointestinal cancer
  • Genitourinary cancer
  • Lung cancer

Icon Locations

Wesley View centre
North Lakes View centre

Visiting Locations

  • North West Private Hospital
  • Greenslopes Private Hospital

Publications

  • Yaxley, W. J., McBean, R., Wong, D., Grimes, D., Vasey, P., Frydenberg, M., & Yaxley, J. W. (2021). Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?. Investigative and clinical urology, 62(6), 650–657.